Drug data last refreshed 16h ago · AI intelligence enriched 4w ago
Sodium Chromate Cr-51 is a radioactive diagnostic agent administered by injection used for blood volume and red blood cell survival studies. It functions as a radiopharmaceutical tracer that binds to red blood cells, enabling clinicians to measure circulating blood volume and assess erythrocyte lifespan. This is a specialized nuclear medicine product with narrow but critical diagnostic applications.
As an aging radiopharmaceutical approaching loss of exclusivity, the brand team is likely small and focused on retention and compliance rather than growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Sodium Chromate Cr-51 offers limited growth and visibility opportunities, as the product is in LOE-approaching stage with no linked job postings and minimal commercial momentum. Career development here would focus on regulatory compliance, manufacturing, and lifecycle management rather than commercial innovation or market expansion.
Worked on SODIUM CHROMATE CR 51 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo